Characteristics of women using organized or opportunistic breast cancer screening in France. Analysis of the 2006 French Health, Health Care and Insurance Survey

Revue d'Epidemiologie et de Sante Publique

Volumn 60, Issue 6, 2012, Pages 421-430

  Duport, N ^a  

^a INSTITUT DE VEILLE SANITAIRE   (France)

Author keywords

Breast cancer screening; France; Healthcare access; Mammography; Sociodemographic status

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BEHAVIOR; BREAST CANCER; CANCER SCREENING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; FRANCE; GYNECOLOGIST; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PAPANICOLAOU TEST; QUESTIONNAIRE; SELF REPORT;

AGED; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; FRANCE; HEALTH CARE SURVEYS; HEALTH SERVICES ACCESSIBILITY; HUMANS; INSURANCE, HEALTH; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; QUESTIONNAIRES;

EID: 84870676438     PISSN: 03987620     EISSN: 17730627     Source Type: Journal    
DOI: 10.1016/j.respe.2012.05.006     Document Type: Article

References (40)

1. Ferlay J., Parkin D.M., Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010, 46:765-781.
2. Belot A., Grosclaude P., Bossard N., Jougla E., Benhamou E., Delafosse P., et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 2008, 56:159-175.
3. Sauvage M., Trétarre B., Grosclaude P., Molonié F., Aude A.M., Danzon A., et al. Sein. Survie des patients atteints de cancer en France 2007, 225-232. Springer, Paris. P. Grosclaude, N. Bossard, L. Remontet, A. Belot, P. Arveux, A.M. Bouvier (Eds.).
4. Arveux P., Wait S., Schaffer P. Building a model to determine the cost-effectiveness of breast cancer screening in France. Eur J Cancer Care 2003, 12:143-153.
5. Fletcher S.W., Elmore J.G. Clinical practice. Mammographic screening for breast cancer. N Engl J Med 2003, 348:1672-1680.
6. Schopper D., de Wolf C. How effective are breast cancers screening programmes by mammography? Review of the current evidence. Eur J Cancer 2009, 45:1916-1923.
7. Perry N., Broeders M., De Wolf C., Törnberg S., Holland R., von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis 2006, Health & Consumer Protection Directorate-General, European Communities, Bruxelles, http://ec.europa.eu/health/ph_projects/2002/cancer/fp_cancer_2002_ext_guid_01.pdf (Consulté le 28/10/2011). 4th ed.
8. Institut de veille sanitaire (French national Institute for Public Health Surveillance), France: .(Consulté le 28/10/2011). http://www.invs.sante.fr/Dossiers-thematiques/Maladies-chroniques-et-traumatismes/Cancers/Evaluation-des-programmes-de-depistage-des-cancers/Evaluation-du-programme-de-depistage-du-cancer-du-sein.
9. Eisinger F., guagliardo V., Julian-Reynier C., Moatti J.P. Dépistage des cancers. Baromètre santé 2000 2001, 329-355. CFES, Vanves. P. Guilbert, F. Baudier, A. Gautier (Eds.).
10. Duport N., Ancelle-Park R. Do socio-demographic factors influence mammography use of French women? Analysis of a French cross-sectional survey. Eur J Cancer Prev 2006, 15:219-224.
11. Duport N., Bloch J. Dépistage du cancer du sein. Baromètre cancer 2005 2006, 119-126. Inpes, Saint-Denis. P. Guilbert, P. Peretti-Watel, F. Beck, A. Gautier (Eds.).
12. Allonier C, Dourgnon P, Rochereau T. Enquête sur la Santé et la Protection Sociale 2006. Paris: Institut de Recherche et Documentation en économie de la Santé, Rapport No.: 1701, 2008. (Consulté le 28/10/2011). http://www.irdes.fr/Publications/Rapports2008/rap1701.pdf.
13. Allonier C, Dourgnon P, Rochereau T. The 2006 Health, Health Care and Insurance Survey, a panel for health policies analysis, public health and health economics research. Paris: Institut de Recherche et Documentation en économie de la Santé, Issues in health economics No. 131, 2008. (Consulté le 28/10/2011). http://www.irdes.fr/EspaceAnglais/Publications/IrdesPublications/QES131.pdf.
14. Moatti J.P., Béja V., Eisinger F., Obadia Y., Alias F., Dressen C. Dépistage des cancers. Baromètre santé 1992 1994, 60-77. CFES, Vanves. F. Baudier, C. Dressen, F. Alias (Eds.).
15. Duport N., Serra D., Goulard H., Bloch J. Quels facteurs influencent la pratique du dépistage des cancers féminins en France ?. Rev Epidemiol Sante Publique 2008, 56:303-313.
16. Séradour B., Allemand H., Weill A., Ricordeau P. Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006. Bull Cancer 2009, 96:E1-E6.
17. Waldron J. Breast Screening Programme, England 2008-09 2010, The National Health Service (NHS) Information Centre, Workforce and Facilities, Leeds, http://www.ic.nhs.uk/webfiles/publications/breast_screening/Breast_Screening_Programme_Report_2008_09.pdf (Consulté le 28/10/2011).
18. Lagerlund M., Maxwell A.E., Bastani R., Thurfjell E., Ekbom A., Lambe M. Socio-demographic predictors of non-attendance at invitational mammography screening: a population-based register study (Sweden). Cancer Causes Control 2002, 13:73-82.
19. Van Harrison R., Janz N.K., Wolfe R.A., Tedeschi P.J., Stross J.K., Huang X., et al. Characteristics of primary care physicians and their practices associated with mammography rates for older women. Cancer 2003, 98:1811-1821.
20. Ostbye T., Greenberg G.N., Taylor D.H., Lee A.M. Screening mammography and Pap tests among older American women 1996-2000: results from the health and retirement study (HRS) and asset and health dynamics among the oldest old (AHEAD). Ann Fam Med 2003, 1:209-217.
21. Kim J., Jang S.N. Socio-economic disparities in breast cancer screening among US women: trends from 2000 to 2005. J Prev Med Public Health 2008, 41:186-194.
22. Martín-López R., Hernández-Barrera V., De Andres A.L., Garrido P.C., De Miguel A.G., García R.J. Breast and cervical cancer screening in Spain and predictors of adherence. Eur J Cancer Prev 2010, 19:239-245.
23. Duport N., Ancelle-Park R., Boussac-Zarebska M., Uhry Z., Bloch J. Are breast cancer screening practices associated with socio-demographic status and healthcare access? Analysis of a French cross-sectional study. Eur J Cancer Prev 2008, 17:218-224.
24. Lagerlund M., Sparén P., Thurfjell E., Ekbom A., Lambe M. Predictors of non-attendance in a population-based mammography screening programme; socio-demographic factors and aspects of health behavior. Eur J Cancer Prev 2000, 9:25-33.
25. Qureshi M., Thacker H.L., Litaker D.G., Kippes C. Differences in breast cancer screening rates: an issue of ethnicity or socio-economics?. J Womens Health Gend Based Med 2000, 9:1025-1031.
26. Schootman M., Jeffe D.B., Reschke A.H., Aft R.L. Disparities related to socio-economic status and access to medical care remain in the United States among women who never had a mammogram. Cancer Causes Control 2003, 14:419-425.
27. Cabeza E., Esteva M., Pujol A., Thomas V., Sánchez-Contador C. Social disparities in breast and cervical cancer preventive practices. Eur J Cancer Prev 2007, 16:372-379.
28. Meissner H.I., Breen N., Taubman M.L., Vernon S.W., Graubard B.I. Which women aren't getting mammograms and why? (United States). Cancer Causes Control 2007, 18:61-70.
29. Poole B., Black C., Gelmon K., Kan L. Is Canadian women's breast cancer screening behavior associated with having a family doctor?. Can Fam Physician 2010, 56:e150-e157.
30. Berkman L.F., Macintyre S. The measurement of social class in health studies: old measures and new formulations. Social inequalities and cancer 2007, 51-64. IARC scientific publications No. 138, Lyon. M. Kogevinas, N. Pearce, M. Susser (Eds.).
31. Facione N.C., Katapodi M. Culture as an influence on breast cancer screening and early detection. Semin Oncol Nurs 2000, 16:238-247.
32. Goldberg M., Melchior M., Leclerc A., Lert F. Les déterminants sociaux de la santé : apports récents de l'épidémiologie sociale et des sciences sociales de la santé. Sci Soc Sante 2002, 20:75-128.
33. Pornet C., Dejardin O., Morlais F., Bouvier V., Launoy G. Socio-economic and healthcare supply statistical determinants of compliance to mammography screening programs: a multilevel analysis in Calvados, France. Cancer Epidemiol 2010, 34:309-315.
34. Moser K., Patnick J., Beral V. Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross-sectional survey data. BMJ 2009, 338:b2025.
35. Wee C.C., McCarthy E.P., Davis R.B., Phillips R.S. Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care?. Ann Intern Med 2000, 132:697-704.
36. Ferrante J.M., Chen P.H., Crabtree B.F., Wartenberg D. Cancer screening in women: body mass index and adherence to physician recommendations. Am J Prev Med 2007, 32:525-531.
37. Maruthur N.M., Bolen S., Brancati F.L., Clark J.M. Obesity and mammography: a systematic review and meta-analysis. J Gen Intern Med 2009, 24:665-677.
38. Flamant C., Gauthier E., Clavel-Chapelon F. Determinants of non-compliance to recommendations on breast cancer screening among women participating in the French E3N cohort study. Eur J Cancer Prev 2006, 15:27-33.
39. Rauscher G.H., Johnson T.P., Cho Y.I., Walk J.A. Accuracy of self-reported cancer screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008, 17:748-757.
40. Howard M., Agarwal G., Lytwyn A. Accuracy of self-reports of Pap and mammography screening compared to medical record: a meta-analysis. Cancer Causes Control 2009, 20:1-13.